Phase II Trial of Pemetrexed and Pembrolizumab in Patients With Recurrent and/or Metastatic Nonadenoid Cystic Salivary Gland Cancer There is a heterogeneous practice pattern in prophylactic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results